Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy

Radiotherapy and Oncology

Volumn 91, Issue 3, 2009, Pages 369-378

  Gay, Hiram A ^a   Sibata, Claudio H ^a   Allison, Ron R ^a   Jeremic, Branislav ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Early stage non small cell lung cancer; Hypofractionated lung radiotherapy; Isodose based planning; Normal tissue dose constraints; Radiobiological analysis

Indexed keywords

ALPHA RADIATION; AORTA DISSECTION; ARTICLE; BETA RADIATION; BRACHIAL PLEXUS; CANCER RADIOTHERAPY; CONTROLLED STUDY; MORTALITY; NEUROPATHY; NOMENCLATURE; OUTCOME ASSESSMENT; PERFORATION; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INJURY; RADIATION RESPONSE; RISK ASSESSMENT; RISK REDUCTION; SKIN MANIFESTATION; SPINAL CORD; TREATMENT DURATION; TREATMENT PLANNING; TUMOR VOLUME;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY;

EID: 65749109576     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.032     Document Type: Article

References (89)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
3. Jeremic B., Classen J., and Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
4. Zimmermann F.B., Bamberg M., Molls M., et al. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol 21 (2003) 91-97
5. Jeremic B., Milicic B., Acimovic L., et al. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study. J Clin Oncol 23 (2005) 6873-6880
6. Jeremic B., Shibamoto Y., Acimovic L., et al. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38 (1997) 521-525
7. Jeremic B., Shibamoto Y., Acimovic L., et al. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 15 (1997) 893-900
8. Bush D.A., Slater J.D., Shin B.B., et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126 (2004) 1198-1203
9. Miyamoto T., Baba M., Sugane T., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2 (2007) 916-926
10. Joyner M., Salter B.J., Papanikolaou N., et al. Stereotactic body radiation therapy for centrally located lung lesions. Acta Oncol 45 (2006) 802-807
11. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
12. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 95 (2002) 1546-1553
13. Hof H., Herfarth K.K., Munter M., et al. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56 (2003) 335-341
14. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
15. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
16. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
17. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
18. Onishi H., Kuriyama K., Komiyama T., et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 45 (2004) 45-55
19. Sinha B., and McGarry R.C. Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience. Int J Radiat Oncol Biol Phys 66 (2006) 1120-1124
20. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
21. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82 (1998) 1062-1070
22. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
23. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114
24. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
25. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
26. Nagata Y., Matsuo Y., Takayama K., et al. Survey of stereotactic body radiotherapy in Japan (abstract). Int J Radiat Oncol Biol Phys 66 Suppl. 1 (2006) S150-S151
27. Turesson I., and Thames H.D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 15 (1989) 169-188
28. Hopewell J.W., Nyman J., and Turesson I. Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity. Int J Radiat Biol 79 (2003) 513-524
29. Nieder C., Grosu A.L., Andratschke N.H., et al. Update of human spinal cord reirradiation tolerance based on additional data from 38 patients. Int J Radiat Oncol Biol Phys 66 (2006) 1446-1449
30. Macbeth F.R., Wheldon T.E., Girling D.J., et al. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The medical research council lung cancer working party. Clin Oncol (R Coll Radiol) 8 (1996) 176-181
31. Bentzen S.M., Skoczylas J.Z., and Bernier J. Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol 76 (2000) 453-462
32. Overgaard M. Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage. Acta Oncol 27 (1988) 117-122
33. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose-response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
34. Powers B.E., McChesney S.L., and Gillette E.L. Late radiation response of the canine trachea with change in dose per fraction. Int J Radiat Oncol Biol Phys 13 (1987) 1673-1680
35. Gillette S.M., Gillette E.L., Shida T., et al. Late radiation response of canine mediastinal tissues. Radiother Oncol 23 (1992) 41-52
36. Wulf J., Baier K., Mueller G., et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87
37. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
38. Anteunis A., Gespach C., Astesano A., et al. VIP inhibits histamine-induced ultrastructural changes related to acid secretion by parietal cells. Peptides 5 (1984) 277-283
39. de Boer W.J., Mehta D.M., Timens W., et al. The short and long term effects of intraoperative electron beam radiotherapy (IORT) on thoracic organs after pneumonectomy an experimental study in the canine model. Int J Radiat Oncol Biol Phys 45 (1999) 501-506
40. Gillette E.L., Powers B.E., McChesney S.L., et al. Response of aorta and branch arteries to experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys 17 (1989) 1247-1255
41. Gillette E.L., Powers B.E., McChesney S.L., et al. Aortic wall injury following intraoperative irradiation. Int J Radiat Oncol Biol Phys 15 (1988) 1401-1406
42. Johnstone P.A., DeLuca A.M., Bacher J.D., et al. Clinical toxicity of peripheral nerve to intraoperative radiotherapy in a canine model. Int J Radiat Oncol Biol Phys 32 (1995) 1031-1034
43. Kinsella T.J., DeLuca A.M., Barnes M., et al. Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol Biol Phys 20 (1991) 697-701
44. Kinsella T.J., Sindelar W.F., DeLuca A.M., et al. Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): clinical and experimental studies. Int J Radiat Oncol Biol Phys 11 (1985) 1579-1585
45. LeCouteur R.A., Gillette E.L., Powers B.E., et al. Peripheral neuropathies following experimental intraoperative radiation therapy (IORT). Int J Radiat Oncol Biol Phys 17 (1989) 583-590
46. Mittal B.B., Pelzer H., Tsao C.S., et al. Intraoperative radiation of canine carotid artery, internal jugular vein, and vagus nerve. Therapeutic applications in the management of advanced head and neck cancers. Arch Otolaryngol Head Neck Surg 116 (1990) 1425-1430
47. Shaw E.G., Gunderson L.L., Martin J.K., et al. Peripheral nerve and ureteral tolerance to intraoperative radiation therapy: clinical and dose-response analysis. Radiother Oncol 18 (1990) 247-255
48. Sindelar W.F., Hoekstra H.J., Kinsella T.J., et al. Response of canine esophagus to intraoperative electron beam radiotherapy. Int J Radiat Oncol Biol Phys 15 (1988) 663-669
49. Sindelar W.F., and Kinsella T.J. Normal tissue tolerance to intraoperative radiotherapy. Surg Oncol Clin N Am 12 (2003) 925-942
50. Vujaskovic Z. Structural and physiological properties of peripheral nerves after intraoperative irradiation. J Peripher Nerv Syst 2 (1997) 343-349
51. Vujaskovic Z., Gillette S.M., Powers B.E., et al. Intraoperative radiation (IORT) injury to sciatic nerve in a large animal model. Radiother Oncol 30 (1994) 133-139
52. Vujaskovic Z., Gillette S.M., Powers B.E., et al. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: neurologic and electrophysiologic study. Int J Radiat Oncol Biol Phys 34 (1996) 125-131
53. Vujaskovic Z., Gillette S.M., Powers B.E., et al. Ultrastructural morphometric analysis of peripheral nerves after intraoperative irradiation. Int J Radiat Biol 68 (1995) 71-76
54. Vujaskovic Z., Powers B.E., Paardekoper G., et al. Effects of intraoperative irradiation (IORT) and intraoperative hyperthermia (IOHT) on canine sciatic nerve: histopathological and morphometric studies. Int J Radiat Oncol Biol Phys 43 (1999) 1103-1109
55. Yamashita H., Nakagawa K., Nakamura N., et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2 (2007) 21
56. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
57. Wang S., Liao Z., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 (2006) 1399-1407
58. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
59. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
60. Gagliardi G., Lax I., and Rutqvist L.E. Partial irradiation of the heart. Semin Radiat Oncol 11 (2001) 224-233
61. Miller K.L., Shafman T.D., Anscher M.S., et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys 61 (2005) 64-69
62. Socinski M.A., Morris D.E., Halle J.S., et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol 22 (2004) 4341-4350
63. Nag S., Kelly J.F., Horton J.L., et al. Brachytherapy for carcinoma of the lung. Oncology (Williston Park) 15 (2001) 371-381
64. Calvo F.A., Ortiz de Urbina D., Abuchaibe O., et al. Intraoperative radiotherapy during lung cancer surgery: technical description and early clinical results. Int J Radiat Oncol Biol Phys 19 (1990) 103-109
65. Gay H.A., Allison R.R., Downie G.H., et al. Toward endobronchial Ir-192 high-dose-rate brachytherapy therapeutic optimization. Phys Med Biol 52 (2007) 2987-2999
66. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
67. Arimoto T., Takamura A., Tomita M., et al. Intraoperative radiotherapy for esophageal carcinoma - significance of IORT dose for the incidence of fatal tracheal complication. Int J Radiat Oncol Biol Phys 27 (1993) 1063-1067
68. Stripp D., and Glatstein E. The good, the bad, and the ugly. Int J Radiat Oncol Biol Phys 61 (2005) 3-4
69. Song D.Y., Benedict S.H., Cardinale R.M., et al. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 28 (2005) 591-596
70. Kawase T., Takeda A., Kunieda E., et al. Symptomatic extrapulmonary soft-tissue fibrosis resulting from hypofractionated stereotactic radiotherapy pulmonary nodular lesion. Int J Radiat Oncol Biol Phys 69 (2007) S495
71. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
72. Schultheiss T.E., and Stephens L.C. Invited review: permanent radiation myelopathy. Br J Radiol 65 (1992) 737-753
73. Schultheiss T.E., Kun L.E., Ang K.K., et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31 (1995) 1093-1112
74. Powell S., Cooke J., and Parsons C. Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 18 (1990) 213-220
75. Galecki J., Hicer-Grzenkowicz J., Grudzien-Kowalska M., et al. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer - a review. Acta Oncol 45 (2006) 280-284
76. Stoll B.A., and Andrews J.T. Radiation-induced peripheral neuropathy. Br Med J 1 (1966) 834-837
77. Hosokawa M., Shirato H., Ohara M., et al. Intraoperative radiation therapy to the upper mediastinum and nerve-sparing three-field lymphadenectomy followed by external beam radiotherapy for patients with thoracic esophageal carcinoma. Cancer 86 (1999) 6-13
78. Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother Oncol 15 (1989) 217-226
79. Alexander M.A., Brooks W.A., and Blake S.W. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy. Phys Med Biol 52 (2007) 1831-1843
80. Giraud P., Antoine M., Larrouy A., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48 (2000) 1015-1024
81. Marks L.B. Extrapolating hypofractionated radiation schemes from radiosurgery data: regarding Hall et al., IJROBP 21:819-824; 1991 and Hall and Brenner, IJROBP 25:381-385; 1993. Int J Radiat Oncol Biol Phys 32 (1995) 274-276
82. Park C., Papiez L., Zhang S., et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 847-852
83. Guerrero M., and Li X.A. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49 (2004) 4825-4835
84. Curtis S.B. Lethal and potentially lethal lesions induced by radiation - a unified repair model. Radiat Res 106 (1986) 252-270
85. Okunieff P., Petersen A.L., Philip A., et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 45 (2006) 808-817
86. Sindelar W.F., Hoekstra H., Restrepo C., et al. Pathological tissue changes following intraoperative radiotherapy. Am J Clin Oncol 9 (1986) 504-509
87. Haedinger U., Krieger T., Flentje M., et al. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Int J Radiat Oncol Biol Phys 61 (2005) 239-249
88. Scholz C., Schulze C., Oelfke U., et al. Development and clinical application of a fast superposition algorithm in radiation therapy. Radiother Oncol 69 (2003) 79-90
89. Matsuo Y., Takayama K., Nagata Y., et al. Interinstitutional variations in planning for stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 416-425